TLR4’s higher expression in relapsing hepatocellular carcinoma patients has recently been linked to its newly discovered regulatory role in the enhancement of stem properties in HCC cells via the TLR4–AKT–SOX2 pathway [231]. This evidence concerns the gene AKT1 and hepatocellular carcinoma.